cisapride has been researched along with cct 137690 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atrash, B; Avery, S; Bavetsias, V; Bayliss, R; Blagg, J; Box, G; Brown, N; Bush, K; Crumpler, S; de Haven Brandon, A; Eccles, SA; Faisal, A; Henley, A; Kosmopoulou, M; Linardopoulos, S; Moore, AS; Raynaud, FI; Sheldrake, PW; Sun, C; Valenti, M; Workman, P | 1 |
1 other study(ies) available for cisapride and cct 137690
| Article | Year |
|---|---|
Optimization of imidazo[4,5-b]pyridine-based kinase inhibitors: identification of a dual FLT3/Aurora kinase inhibitor as an orally bioavailable preclinical development candidate for the treatment of acute myeloid leukemia.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Aurora Kinase A; Aurora Kinase B; Aurora Kinases; Biological Availability; Cell Line, Tumor; Drug Screening Assays, Antitumor; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Female; fms-Like Tyrosine Kinase 3; Humans; Imidazoles; Leukemia, Myeloid, Acute; Male; Mice; Mice, Inbred BALB C; Microsomes, Liver; Models, Molecular; Mutation; Neoplasm Transplantation; Protein Serine-Threonine Kinases; Purines; Pyrazoles; Pyridines; Rats; Rats, Sprague-Dawley; Transplantation, Heterologous | 2012 |